Mixed Goblet Cell Carcinoid-Adenocarcinoma: A Case Series by Espinosa, Jairo, M.D. et al.
Western Michigan University
ScholarWorks at WMU
Research Day WMU Homer Stryker M.D. School of Medicine
2017
Mixed Goblet Cell Carcinoid-Adenocarcinoma: A
Case Series
Jairo Espinosa M.D.
Western Michigan University Homer Stryker M.D. School of Medicine
Timothy Truong
Western Michigan Homer Stryker M.D. School of Medicine
Julia Miladore M.D.
Western Michigan Homer Stryker M.D. School of Medicine
John T. Collins
Borgess Medical Center
Saad Shebrain M.D.
Western Michigan Homer Stryker M.D. School of Medicine
See next page for additional authors
Follow this and additional works at: http://scholarworks.wmich.edu/medicine_research_day
Part of the Life Sciences Commons, and the Surgery Commons
This Abstract is brought to you for free and open access by the WMU
Homer Stryker M.D. School of Medicine at ScholarWorks at WMU. It has
been accepted for inclusion in Research Day by an authorized administrator
of ScholarWorks at WMU. For more information, please contact
maira.bundza@wmich.edu.
WMU ScholarWorks Citation
Espinosa, Jairo M.D.; Truong, Timothy; Miladore, Julia M.D.; Collins, John T.; Shebrain, Saad M.D.; and Munene, Gitonga M.D.,
"Mixed Goblet Cell Carcinoid-Adenocarcinoma: A Case Series" (2017). Research Day. 24.
http://scholarworks.wmich.edu/medicine_research_day/24
Authors
Jairo Espinosa M.D., Timothy Truong, Julia Miladore M.D., John T. Collins, Saad Shebrain M.D., and Gitonga
Munene M.D.
This abstract is available at ScholarWorks at WMU: http://scholarworks.wmich.edu/medicine_research_day/24
Mixed Goblet Cell Carcinoid-Adenocarcinoma – A Case Series
Jairo A. Espinosa MD, Timothy Truong, Julia Miladore MD, Saad Shebrain MD
Gitonga Munene MD, John T. Collins MD
Mixed goblet cell carcinoid-adenocarcinoma (GCC) tumors are a group of rare
heterogeneous neoplasms of the appendix first described in 1969 by Gagne et al
that account for < 5% of all primary appendiceal tumors.1,2 These hybrid tumors
are characterized as an intermediate between classic carcinoid tumors and
appendiceal adenocarcinomas, exhibiting both neuroendocrine and
glandular/mucinous morphology that most commonly presents in Caucasian
females in the fifth and sixth decades.1,3–6 Their distinct glandular and
neuroendocrine differentiation has led to multiple names and designations
including adenocarcinoids, mucinous-carcinoid, mixed carcinoid-adenocarcinoma,
microglandular goblet cell carcinoma, and crypt cell adenocarcinoma.7 A broader
classification system has been suggested for GCC tumors based on their histologic
appearance.3 The system classifies the tumors into 3 sub-groups: typical goblet
cell carcinoid (Group A), adenocarcinoma ex-goblet cell carcinoid; signet-ring cell
type (group B), and adenocarcinoma ex-goblet cell carcinoid; poorly differentiated
carcinoma type (group C).3 The most common presentation for GCC tumors is
acute appendicitis.3,8 We present three cases of mixed goblet cell carcinoid-
adenocarcinoma presenting as acute appendicitis.
INTRODUCTION
CASE PRESENTATIONS 
Case #1 involved a 65-year-old male who presented with right lower quadrant
pain, nausea, emesis, and leukocytosis. A CT scan of the abdomen revealed
perforated appendicitis. The patient underwent a laparoscopic appendectomy.
Pathology revealed a high-grade adenocarcinoma ex goblet cell carcinoid, signet
ring type extending through the muscularis propria and into the mesoappendix
measuring >3cm. The patient subsequently underwent a colonoscopy that
revealed diverticulosis involving the sigmoid colon, but was otherwise normal.
Labs revealed that CEA, CA-125, and chromogranin A were negative. Patient then
underwent an exploratory laparotomy with a right hemicolectomy and partial
omentectomy. Pathology revealed normal ileal and colonic mucosa without
evidence of carcinoma. Omental specimen showed no evidence of metastatic
carcinoma. 0/12 nodes were positive for metastatic carcinoma.
Case #2 involved a 49-year-old male who presented with periumbilical pain,
nausea, emesis, and leukocytosis. A CT scan of the abdomen revealed
appendicitis. The patient underwent an uneventful laparoscopic appendectomy.
Pathology revealed a high-grade, poorly differentiated, adenocarcinoma ex
goblet cell carcinoid invading through the muscularis propria and into the
periappendiceal soft tissue measuring 1.5cm. The patient subsequently
underwent a colonoscopy that revealed diverticulosis involving the sigmoid
colon, but was otherwise normal. Patient then underwent an uneventful
laparoscopic right hemicolectomy. Pathology revealed normal ileal and colonic
mucosa without evidence of carcinoma. 0/14 nodes were positive for
metastatic carcinoma.
Case #3 involved a 70-year-old female who presented with periumbilical pain. A
CT scan of the abdomen revealed appendicitis. The patient underwent an
uneventful laparoscopic appendectomy. Pathology revealed a high-grade
adenocarcinoma ex goblet cell carcinoid extending through the muscularis
propria and into the mesoappendix measuring 4cm. Patient then underwent an
exploratory laparotomy with a right hemicolectomy. Pathology revealed normal
ileal and colonic mucosa without evidence of carcinoma. 0/21 nodes were
positive for metastatic carcinoma.
CONCLUSION
Mixed goblet cell carcinoid-adenocarcinoma tumors are rare tumors that tend to
present at an advanced stage with up to 40% positive lymphadenopathy and most
commonly spread via direct extension.8 Surgical resection with a right hemi-
colectomy after an appendectomy has been shown to improve the prognosis and
is thus recommended in most cases.9,10 HIPEC and adjuvant chemotherapy are
other therapeutic options, but have not been shown to improve survival.11 The
adjuvant chemotherapy recommended composes of 5-florouracil (5-FU), FOLFOX
(5-FU, leucovorin, and oxaliplatin), and FOLFIRI(5-FU, folic acid, and irinotecan).7,9
In the current age of increasing rates of managing acute appendicitis non-
operatively we strongly encourage surgical appendectomy in patients older than
45 years of age to avoid missing this important diagnosis and the opportunity to
treat it in a timely manner.
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Table 1. TNM Staging of Mixed Goblet Cell 
Carcinoid-Adenocarcinoma
Stage T N M
I T1: Tumor <2cm N0 M0
II T2 or T3
T2: Tumor 2-4cm 
T3: Tumor >4cm
N0 M0
III ANY T
T4: Tumor invading 
adjacent organs
N1: Metastasis to 
regional LN’s
M0
IV Any T Any N M1
Image 1. CT imaging displaying acute 
appendicitis
Image 2. H & E stain demonstrating clusters of goblet cells invading 
the muscular wall of the appendix as seen in Group A mixed goblet 
cell carcinoid-adenocarcinoma12
